About: TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Sector: Healthcare
Industry: Medical Devices
Latest price: $72.76 (+8.04%)
TMDX NASDAQ TransMedics Group Inc
TransMedics Group Inc share price
TMDX price activity
Last Price
$72.760
Change (24hr)
5.42 USD (8.04%)
Volume
2.47M
Volume (4w avg)
-
Open
$69.97
Day Range
$68.67 - $74.67
Previous Close
$67.34
Last Trade
04 Nov, 9:22 pm GMT+0
Delayed
04 Nov, 9:22 pm GMT+0
TMDX price performance
Delayed
04 Nov, 9:22 pm GMT+0
TMDX details
TMDX Market Signals